Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-acetylamino-4-methyl-pentanoic acid (1-formyl-2-phenyl-ethyl)-amide
- Development stage
- Unknown
- Modality
- Peptides, Small Molecules
01
Overview
2-Acetylamino–4-methyl-pentanoic acid (1-formyl–2‑phenylethyl)‑amide is a synthetic small molecule peptide derivative, structurally related to leucine and phenylaniline. It is not an approved drug in the US or other major markets and is classified as experimental. The compound has been studied primarily for its biochemical properties and potential as a research tool, particularly in protein interaction studies due to its peptide-like structure. There are no known clinical indications or established mechanisms of action for this compound in humans[1][2][3].
- Other names
- 2-acetylamino-4-methyl-pentanoic acid (1-formyl-2-phenyl-ethyl)-amide(2S)-2-acetamido-4-methyl-N-(1-oxo-3-phenylpropan-2-yl)pentanamideN-acetyl-L-leucyl-L-phenylalaninalAc-Leu-Phe-al
Beyond the preview
Go deeper on 2-acetylamino-4-methyl-pentanoic acid (1-formyl-2-phenyl-ethyl)-amide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-acetylamino-4-methyl-pentanoic acid (1-formyl-2-phenyl-ethyl)-amide.